S3 used in combination with Docetaxel showed a clear trend towards increased inhibition compared to each single treatment, although data did not reach statistical significance ( Figure 8 A).
← all excerpts
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy.
1
—
—